Christophe Soulier
Director Financiero/CFO en Janssen Pharmaceuticals, Inc. .
Perfil
Christophe Soulier is currently the Director-Global Finance, Research & Development at Janssen Pharmaceuticals, Inc. since 2011.
He is also currently the Director at Johnson & Johnson Innovation Ltd.
starting in 2023.
Previously, he worked as the Finance Director at Johnson & Johnson from 2005 to 2007.
Mr. Soulier holds an MBA from the University of Michigan, which he obtained in 2002.
He also completed his undergraduate studies at Collège Stanislas de Paris in 1989.
Cargos activos de Christophe Soulier
| Empresas | Cargo | Inicio |
|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Director Financiero/CFO | 01/11/2007 |
Johnson & Johnson Innovation Ltd.
 Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Inversor de Capital Privado | 08/02/2023 |
Antiguos cargos conocidos de Christophe Soulier.
| Empresas | Cargo | Fin |
|---|---|---|
| JOHNSON & JOHNSON | Director Financiero/CFO | 01/10/2007 |
Formación de Christophe Soulier.
| University of Michigan | Masters Business Admin |
| Collège Stanislas de Paris | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Empresas privadas | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Johnson & Johnson Innovation Ltd.
Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Finance |
- Bolsa de valores
- Insiders
- Christophe Soulier